These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 13736141)

  • 1. Endocrine suppression of lactation with Deladumone 2X.
    PIVER JS
    Med Ann Dist Columbia; 1961 May; 30():264-6. PubMed ID: 13736141
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone therapy for the non-nursing mother, a comparative study of Tace, Deladumone 2X and placebo.
    MANNING RE
    Ohio State Med J; 1961 Jan; 57():39-41. PubMed ID: 13766244
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of Deladumone. The control of postpartum breast engorgement lactation and pain.
    BISCA BV; TETERIS NJ; YANNONE ME
    Ohio State Med J; 1962 Mar; 58():303-5. PubMed ID: 13869460
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of delahormones on lactation in the nursing mother. A new approach.
    NAPIER J; BENSON RC; HOPKINS CE
    Trans Pac Coast Obstet Gynecol Soc; 1959; 27():72-8. PubMed ID: 14425988
    [No Abstract]   [Full Text] [Related]  

  • 5. Ablaton: single intramuscular injection to suppress lactation.
    Kuah KB
    Med J Malaysia; 1975 Mar; 30(3):223-6. PubMed ID: 1160683
    [No Abstract]   [Full Text] [Related]  

  • 6. [Suppression of lactation by a combination of testosterone enanthate and estradiol valerianate].
    BUCHER J
    Bull Fed Soc Gynecol Obstet Lang Fr; 1960; 12():156-7. PubMed ID: 13805538
    [No Abstract]   [Full Text] [Related]  

  • 7. An evaluation of a combination of testosterone enanthate with estradiol valerate (deladumone) for the inhibition of lactation.
    STEIN WW
    Am J Obstet Gynecol; 1958 Jul; 76(1):108-17. PubMed ID: 13545286
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of hormone therapy for suppression of lactation.
    WOMACK WS; SMITH SW; ALLEN GM; BAKER RL; CHRISTENSEN OD; GALLAHER JP; HANSON IR; SMITH WB; GOMEZ AC
    South Med J; 1962 Aug; 55():816-20. PubMed ID: 14008127
    [No Abstract]   [Full Text] [Related]  

  • 9. [Suppression of lacation by injection of testosterone enanthate and of estradiol valerianate during labor or immediately after delivery. (Apropos of 579 cases)].
    VAN DEN HAUTE C
    Bull Soc R Belge Gynecol Obstet; 1962; 32():291-306. PubMed ID: 13924536
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of hormone dosage and time of administration on suppression of lactation.
    FOLEY WE
    Am J Obstet Gynecol; 1961 Oct; 82():856-9. PubMed ID: 13893836
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of lactation. Advantages of immediate parenteral administration of androgen-estrogen.
    RODENBERG TA; SIMON HJ
    Obstet Gynecol; 1960 Apr; 15():522-5. PubMed ID: 14438143
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of Deladumone OB in the suppression of postpartum lactation.
    Louviere RL; Upton RT
    Am J Obstet Gynecol; 1975 Mar; 121(5):641-2. PubMed ID: 1090174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of an oral androgen-estrogen combination for suppression of lactation.
    PRICE JJ
    Med Times; 1960 Nov; 88():1337-40. PubMed ID: 13737971
    [No Abstract]   [Full Text] [Related]  

  • 14. Is postpartum atrophy of the breast an iatrogenic disease?
    Ryan RF; Pernoll ML
    Plast Reconstr Surg; 1981 Sep; 68(3):456-7. PubMed ID: 7267823
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of postpartum lactation by administration of deladumone during labor.
    LO PRESTO B; CAYPINAR EY
    J Am Med Assoc; 1959 Jan; 169(3):250-2. PubMed ID: 13610656
    [No Abstract]   [Full Text] [Related]  

  • 16. Lactation inhibition by deladumone injected during labor or just after delivery.
    WATROUS JB; AHEARN RE; CARVALHO MA
    J Am Med Assoc; 1959 Jan; 169(3):246-9. PubMed ID: 13610655
    [No Abstract]   [Full Text] [Related]  

  • 17. Testosterone enanthate (180 mg.) and estradiol valerate (8 mg.) for suppression of lactation: a double-blind evaluation.
    Iliya FA; Safon L; O'Leary JA
    Obstet Gynecol; 1966 May; 27(5):643-5. PubMed ID: 5949195
    [No Abstract]   [Full Text] [Related]  

  • 18. Is postpartum atrophy of the breast an iatrogenic disease?
    Ryan RF; Pernoll ML
    Plast Reconstr Surg; 1981 Oct; 68(4):647-8. PubMed ID: 7280113
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative controlled study of hormones used in the prevention of postpartum breast engorgement and lactation.
    MARKIN KE; WOLST MD
    Am J Obstet Gynecol; 1960 Jul; 80():128-37. PubMed ID: 14421258
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a new preparation for the suppression of lactation.
    KELLY MJ; PRIMROSE T
    Can Med Assoc J; 1960 Dec; 83(24):1240-2. PubMed ID: 13752392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.